Analyzing Clinical Trial Experiences of Prostate Cancer Patients

Analyzing Clinical Trial Experiences of Prostate Cancer Patients To Determine How Trial Attributes Affect Completion Rates For Specific Demographic Groups

Participation in clinical trials usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the participation or completion of these specific demographic groups.

This study will admit a wide range of data on the clinical trial experience of Prostate Cancer patients to determine which factors prevail in limiting a patient's ability to join or finish a trial.

It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might shed insights for the sake of future Prostate Cancer patients.

Inclusion Criteria:

• Patient has been diagnosed with Prostate Cancer as identified by imaging
• Patient has self-identified as planning to enroll in an interventional clinical trial for Prostate Cancer
• Patient is at least 18 years of age

Exclusion Criteria:

• Patient does not understand, sign, and return consent form
• Inability to perform regular electronic reporting
• Patient has a ECOG score of 4